Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact: IPAThe Indian Pharmaceutical Alliance (IPA) has called for a clear distinction between spurious and sub-standard drugs following a CDSCO repor...
29 Sep, 2024, 04.15 PM IST
CDSCO finds 50 common medicines substandard, including those for fever, blood pressure, diabetes, and acid refluxMore than 50 drugs for common conditions like high blood pressure, acid reflux, and erectile dysfunction have been found to be not-of-stand...
26 Sep, 2024, 11.08 AM IST
40 medical devices, bulk drug units take off under PLIMinister for Chemicals and Fertilisers Mansukh Mandaviya said the country has taken a big step towards self-reliance, with the commissionin...
02 Mar, 2024, 11.08 PM IST
NPPA fixes retail prices of 23 drug formulationsSimilarly, the retail price of one tablet of Telmisartan, Chlorthalidone & Cilnidipine tablets at Rs 13.17. The retail price of one tablet ...
09 Jun, 2023, 06.27 PM IST
NPPA fixes retail price of 74 drug formulationsThe NPPA said it has also revised the ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutro...
27 Feb, 2023, 07.29 PM IST
NPPA fixes retail price of 74 drug formulationsThe NPPA said it has also revised the ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutro...
27 Feb, 2023, 07.20 PM IST
Glenmark Life IPO opens next week; dates, price band announcedAt the higher end of the price band, the company is expected to raise Rs 1,513.6 crore via its initial shale sale. The promoter holds 100 p...
21 Jul, 2021, 12.10 PM IST
Sun Pharma, Alembic recall products in US marketAccording to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.
18 Apr, 2021, 11.47 AM IST
Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
04 Jun, 2020, 08.27 AM IST
Key diabetes, anti-cancer drugs among 92 in price-ceiling listThe National Pharmaceutical Pricing Authority said in orders dated August 13 that manufacturers of these drugs will fix their retail prices...
17 Aug, 2018, 08.12 AM IST
NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.
02 Jan, 2018, 04.45 PM IST
Alembic Pharma gets USFDA nod for hypertension tabletsUSFDA approves Alembic Pharma's Telmisartan and Amlodipine tablets, generic version of Boehringer Ingelheim Pharmaceuticals Inc's Twynsta t...
18 Nov, 2016, 05.52 PM IST
Aurobindo Pharma gets USFDA nod for generic hypertension tabletsAurobindo now has a total of 211 ANDA approvals (183 final approvals including 9 from Aurolife Pharma LLC and 28 tentative approvals) from ...
04 Sep, 2015, 03.52 PM IST
Expect 12-15% growth from US market in FY15: Glenn SaldanhaWe did not get any new approval in Q1 and last year also we struggled a little bit in terms of getting product approvals, says Glenn Saldan...
26 Jul, 2014, 05.07 PM IST
Glenmark to launch anti-hypertension drug in US, gets USFDA nodGlenmark's current portfolio consists of 92 products authorised for distribution in the US market and 73 ANDAs are pending approval with th...
08 Jul, 2014, 01.09 PM IST
Dr Reddy's Laboratories expects 8-10 pc growth in India generics business this fiscalDRL expects its Indian generic market to grow by 8-10% in the current financial year despite challenges such as price erosion due to new dr...
10 Jan, 2014, 09.46 PM IST
- Cipla in talks to supply drugs to Germany’s BI
Boehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.
16 Dec, 2009, 02.34 AM IST